BiopharmaTrend: Where Tech Meets Bio

BioPharmaTrend

Latest News

AI-Powered Immune Mapping Company Appoints Ex-Pfizer R&D …

AI-Powered Immune Mapping Company Appoints Ex-Pfizer R&D Chief to Its Board

Immunai has appointed Mikael Dolsten, M.D., Ph.D., former Chief Scientific Officer and President of Research & Development at Pfizer, to its Board of Directors. Dolsten … Read More

Cortical Labs Launches $35K Biological Computer Built …

Cortical Labs Launches $35K Biological Computer Built on Human Brain Cells

Cortical Labs has launched the CL1, a biological computing system that integrates human brain cells with silicon hardware to create dynamic neural networks. Branded as … Read More

Novo Nordisk and Gensaic Collaborate on Tissue-Targeted …

Novo Nordisk and Gensaic Collaborate on Tissue-Targeted Therapies for Cardiometabolic Diseases

Gensaic has announced a collaboration with Novo Nordisk to develop targeted therapies for cardiometabolic diseases, utilizing its ligand discovery platform. Under the agreement, Gensaic is … Read More

Google Cloud Introduces Multimodal AI for Healthcare at HIMSS 2025

Vevo Therapeutics Open-Sources Largest Single-Cell Dataset with Arc Institute

Fuse Vectors Secures $5.2M to Develop Cell-Free Gene Therapy Technology

100 Billion Reads Per Day: Ultima Genomics Expands Sequencing Capacity

Roche Introduces New DNA Sequencing Technology

AI-Driven Robotics Lab Identifies TNIK Inhibition as a Novel Way to Curb Inflammatory Aging

Read latest news ›››

Latest Insights

Key Trends in Aging Research: Where Are …

by Andrii Buvailo, PhD

Key Trends in Aging Research: Where Are We Now?

Over the past decade, aging research has transitioned from foundational biological studies, including a landmark introduction of 9 hallmarks of aging back in 2013 and … Read More

Microbiome, Aging, and the Synthetic Immune System: …

by Andrii Buvailo, PhD

Microbiome, Aging, and the Synthetic Immune System: A New Frontier in Geroscience

What does aging have in common with pathogens like bacteria and viruses? And how does the quest to tackle antimicrobial drug resistance -- an alarmingly … Read More

AI in Drug Safety: From Concept to Reality, The Industry's Path Forward

by Dr. Karthik Muthusamy

Marking the Path Ahead: Integrating Oncology Biomarkers Into Clinical Development

by Bea Mann, PhD

Combination Therapies May Be the Future of Oncology – How Can We Navigate Development Challenges Today?

by Andreas Dreps, Bea Mann, PhD

The Future of Advanced Therapeutics: Opportunities and Challenges

by Sai Bhamidipati

What CROs Cite as Their Top Clinical Trial Challenges and How They Plan to Overcome Them in 2025

by Megan Deegan

21 Life Science Marketplaces to Try in 2024

by Andrii Buvailo

FTI Survey: Healthcare & Life Sciences Optimism, M&A and AI to Drive 2025 Growth

by BiopharmaTrend

Chemistry CROs at a Crossroads: How SpiroChem Is Adapting to Market Shifts in 2025 and Beyond

by Thomas Fessard

Read all insights ›››

From Our Partners

Read All ›››

How AI Empowers Biomarker-Driven Clinical Trials

Sponsored by Lantern Pharma

How AI Empowers Biomarker-Driven Clinical Trials

AI Is Key to Democratizing Drug Discovery

Sponsored by OPTIC

AI Is Key to Democratizing Drug Discovery

Beyond Traditional Clinical Trials: MEDSIR’s Adaptive Designs …

Sponsored by MEDSIR

Beyond Traditional Clinical Trials: MEDSIR’s Adaptive Designs and Precision Medicine in Oncology

Patented AI Platform Identifies Promising Early-Stage BioPharma …

Sponsored by Intelligencia AI

Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Companies

Partner Events

View all events ›››

22nd BioPharma Clinical Trials Nexus Conference

22nd BioPharma Clinical Trials Nexus Conference

Event Date: March 13, 2025 - March 14, 2025

Location: Switzerland (Basel)

Website: Link

BIOCHINA 2025

Event Date: March 13, 2025 - March 15, 2025

Location: China (Suzhou International Expo Center)

Website: Link

Global Clinical Trials Connect 2025

Global Clinical Trials Connect 2025

Event Date: May 28, 2025 - May 29, 2025

Location: United Kingdom (London)

Website: Link

London Biotechnology Show 2025

London Biotechnology Show 2025

Event Date: June 18, 2025 - June 19, 2025

Location: United Kingdom (Hall N7 & N8 Bett Global, Excel London, Royal Victoria Dock, 1 Western Gateway, London, UK, England, GB, E16 1XL)

Website: Link

The 12th Aging Research & Drug Discovery Meeting The 11th Aging Research & Drug Discovery Meeting

The 12th Aging Research & Drug Discovery Meeting The 11th Aging Research & Drug Discovery Meeting

Event Date: Aug. 25, 2025 - Aug. 29, 2025

Location: Denmark (Ceremonial Hall, University of Copenhagen)

Website: Link

22nd BioPharma Drug Discovery Nexus Conference Belgium

22nd BioPharma Drug Discovery Nexus Conference Belgium

Event Date: April 29, 2026 - April 29, 2026

Location: Belgium (Brussels, Holiday Inn)

Website: Link

Case Studies

Read All ›››

Using End-to-End Wet Lab Automation Combined with …

Sponsored by Arctoris

Using End-to-End Wet Lab Automation Combined with Machine Learning to Industrialize Drug Discovery

How Astellas Pharma Achieves R&D Operational Excellence …

Sponsored by Science Exchange

How Astellas Pharma Achieves R&D Operational Excellence with Science Exchange

Busting the PoseBusters v3: AI Docking Software …

Sponsored by RECEPTOR.AI

Busting the PoseBusters v3: AI Docking Software ArtiDock Beats Industry’s State of the Art in Speed and Accuracy

QUAISAR Computational Platform for Designing Targeted Protein …

Sponsored by Roivant Sciences

QUAISAR Computational Platform for Designing Targeted Protein Degraders

Powering Cancer Drug Discovery and Development Using …

Sponsored by Lantern Pharma

Powering Cancer Drug Discovery and Development Using the Artificial Intelligence and Machine Learning Platform RADR®

Cyclica's Chemical Probes for DCAF1

Sponsored by Cyclica

Cyclica's Chemical Probes for DCAF1

Application of AI-driven Xanthos Platform for Designing …

Sponsored by Celeris Therapeutics

Application of AI-driven Xanthos Platform for Designing Protein Degraders

Identifying High Impact Tissue Sparing E3 Ligases …

Sponsored by Kymera Therapeutics

Identifying High Impact Tissue Sparing E3 Ligases and Their Binders

Interviews

Read All ›››

Democratizing Early Drug Discovery through Artificial Intelligence: …

Democratizing Early Drug Discovery through Artificial Intelligence: Interview with Syntekabio CEO Jongsun Jung

Rethinking Clinical Trials: Tim Smith on Medable’s …

Rethinking Clinical Trials: Tim Smith on Medable’s Approach to Speed and Efficiency

[Interview] This Company Brings Quantum Tech Into …

[Interview] This Company Brings Quantum Tech Into Protein Design

Blending Biology and AI: Dr. Markus Gershater …

Blending Biology and AI: Dr. Markus Gershater on the Future of Life Sciences

Most Read

14 Companies Using Quantum Theory To Accelerate …

14 Companies Using Quantum Theory To Accelerate Drug Discovery (Including 2 Going Public)

AI Drug Discovery: Key Trends and Developments …

AI Drug Discovery: Key Trends and Developments in Pharmaceutical Industry

7 Promising RNA Biotech Companies To Watch …

7 Promising RNA Biotech Companies To Watch in 2024

11 Notable Companies Enabling Decentralized Clinical Trials

11 Notable Companies Enabling Decentralized Clinical Trials